Drug Patents owned by Biogen Inc
1. List of Tecfidera drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8399514 | BIOGEN INC | Treatment for multiple sclerosis |
Feb, 2028
(4 years from now) | |
| US10391160 | BIOGEN INC | Dimethyl fumarate and vaccination regimens |
Mar, 2035
(12 years from now) | |
| US10994003 | BIOGEN INC | Dimethyl fumarate and vaccination regimens |
Mar, 2035
(12 years from now) | |
| US10555993 | BIOGEN INC | Dimethyl fumarate and vaccination regimens |
Mar, 2035
(12 years from now) | |
| US11129806 | BIOGEN INC | Methods of treating multiple sclerosis |
Nov, 2035
(12 years from now) | |
| US10959972 | BIOGEN INC | Methods of treating multiple sclerosis |
Nov, 2035
(12 years from now) | |
| US11246850 | BIOGEN INC | Methods of treating multiple sclerosis |
Nov, 2035
(12 years from now) | |
| US11007166 | BIOGEN INC | Methods of treating multiple sclerosis |
Nov, 2035
(12 years from now) | |
| US11007167 | BIOGEN INC | Methods of treating multiple sclerosis |
Nov, 2035
(12 years from now) | |
| Exclusivity | Exclusivity Expiration |
|---|---|
| M | Feb 5, 2023 |
Drugs and Companies using DIMETHYL FUMARATE ingredient
Market Authorisation Date: 27 March, 2013
Treatment: Method of treating multiple sclerosis; Method of treating relapsing forms of multiple sclerosis before and after administering an inactive vaccine
Dosage: CAPSULE, DELAYED RELEASE;ORAL
TECFIDERA family patents
21
United States
7
Australia
6
China
4
Morocco
4
Japan
4
European Union
2
Korea, Republic of
2
Canada
2
Israel
2
Mexico
2
EA
1
South Africa
1
New Zealand
2. List of Vumerity drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US8669281 | BIOGEN INC | Prodrugs of fumarates and their use in treating various diseases |
Sep, 2033
(10 years from now) | |
| US10080733 | BIOGEN INC | Prodrugs of fumarates and their use in treating various diseases |
Sep, 2033
(10 years from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9090558 | BIOGEN INC | Prodrugs of fumarates and their use in treating various diseases |
Sep, 2033
(10 years from now) | |
Drugs and Companies using DIROXIMEL FUMARATE ingredient
Market Authorisation Date: 29 October, 2019
Treatment: Method of treating multiple sclerosis
Dosage: CAPSULE, DELAYED RELEASE;ORAL
VUMERITY family patents
18
United States
4
Singapore
4
New Zealand
3
Australia
3
Canada
2
Korea, Republic of
2
Lithuania
2
Israel
2
Japan
2
Hungary
2
China
2
EA
2
European Union
1
Hong Kong
1
RS
1
Brazil
1
Poland
1
Ukraine
1
Spain
1
Cyprus
1
Mexico
1
Slovenia
1
Portugal
1
Croatia
1
Denmark
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic